Gil Bar‐Sela
Impact in
- Molecular Medicine top 1%
- Curcumin's Biomedical Applications
-
- Complementary and Alternative Medicine Studies
Papers in
- Oncology 76
- Colorectal Cancer Treatments and Studies 12
- Cancer Immunotherapy and Biomarkers 12
-
- Complementary and Alternative Medicine Studies 17
- Co-authors
- Ron EpelbaumMoshe SchafferNissim HaimIlit TurgemanEran Ben‐AryeAbraham KutenEdmond SaboVladimir Badmaev
- Journals
- Annals of Oncology (9 papers)Journal of Clinical Oncology (8 papers)Supportive Care in Cancer (8 papers)Anti-Cancer Drugs (7 papers)Medical Oncology (6 papers)
- Partner nations
- IsraelUnited StatesFrance
In The Last Decade
Gil Bar‐Sela
187 papers receiving 4.4k citations
Peers
Comparison fields: 5 of 155
- Molecular Medicine 448
- Complementary and alternative medicine 416
- Oncology 1.3k
- Pharmacology 651
- Conservation 115
Countries citing papers authored by Gil Bar‐Sela
This map shows the geographic impact of Gil Bar‐Sela's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gil Bar‐Sela with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gil Bar‐Sela more than expected).
Fields of papers citing papers by Gil Bar‐Sela
This network shows the impact of papers produced by Gil Bar‐Sela. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gil Bar‐Sela. The network helps show where Gil Bar‐Sela may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Gil Bar‐Sela, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2025 | 0 | |
| 3 | 2024 | 4 | |
| 4 | 2024 | 1 | |
| 5 | 2024 | 4 | |
| 6 | 2023 | 1 | |
| 7 | 2023 | 0 | |
| 8 | 2023 | 3 | |
| 9 | 2022 | 5 | |
| 10 | 2019 | 219 | |
| 11 | 2019 | 48 | |
| 12 | 2019 | 32 | |
| 13 | [FROM PASTORAL CARE TO SPIRITUAL CARE - TRANSFORMING THE CONCEPTION OF THE ROLE OF THE SPIRITUAL CARE PROVIDER]. | 2017 | 5 |
| 14 | [DO WE HAVE MEDICAL MEASURES THAT ATTEST TO THE EFFECT OF SPIRITUAL CARE IN TIME OF ILLNESS?] | 2017 | 1 |
| 15 | 2017 | 12 | |
| 16 | 2015 | 51 | |
| 17 | 2008 | 41 | |
| 18 | 2008 | 79 | |
| 19 | The use of complementary and alternative therapies by cancer patients in northern Israel. | 2005 | 17 |
| 20 | 2004 | 5 |
About Gil Bar‐Sela
Gil Bar‐Sela is a scholar working on Oncology, Complementary and alternative medicine, Health, Pharmacology and Gastroenterology, having authored 199 papers that have together received 4.5k indexed citations. Recurring topics across this work include Palliative Care and End-of-Life Issues (31 papers), Cannabis and Cannabinoid Research (19 papers), Complementary and Alternative Medicine Studies (17 papers), Colorectal Cancer Treatments and Studies (12 papers), Cancer Immunotherapy and Biomarkers (12 papers), Religion, Spirituality, and Psychology (12 papers), Sarcoma Diagnosis and Treatment (10 papers) and Childhood Cancer Survivors' Quality of Life (10 papers). The work is most often cited by research in Molecular Medicine (448 citations), Complementary and alternative medicine (416 citations), Oncology (1.3k citations), Pharmacology (651 citations) and Conservation (115 citations). Gil Bar‐Sela has collaborated with scholars based in Israel, United States and France. Frequent co-authors include Ron Epelbaum, Moshe Schaffer, Nissim Haim, Ilit Turgeman, Eran Ben‐Arye, Abraham Kuten, Edmond Sabo, Vladimir Badmaev, Mira Wollner and Michael Schultz. Their work appears in journals such as Annals of Oncology, Journal of Clinical Oncology, Supportive Care in Cancer, Anti-Cancer Drugs and Medical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.